Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy

References

• SeigalRNaishadhamDJemalACancer statisticsCA Cancer J Clin2012621102922237781
   PubMed Web of Science ®Google Scholar
• GoffBAMandelLMuntzHGMelanconCHovarian carcinoma diagnosisCancer200089102068207511066047
   PubMed Web of Science ®Google Scholar
• OzolsRFTreatment goals in ovarian cancerInt J Gynecol Cancer200515Suppl 1S3S11
   PubMed Web of Science ®Google Scholar
• SugarbakerPHPeritoneal Carcinomatosis Principles of Management1st edBostonKluwer1996
   Google Scholar
• BristowREPuriIChiDSCytoreductive surgery for recurrent ovarian cancer: a meta-analysisGynecol Oncol2009112126527418937969
   PubMed Web of Science ®Google Scholar
• ArmstrongDKBundyBWenzelLIntraperitoneal cisplatin and paclitaxel in ovarian cancerN Engl J Med20063541344316394300
   PubMed Web of Science ®Google Scholar
• JaabackKJohnsonNLawrieTAIntraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer [review]Cochrane Database Syst Rev201111CD00534022071822
   PubMed Web of Science ®Google Scholar
• WitkampAJde BreeEVan GoethemRZoetmulderFARationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy [review]Cancer Treat Rev200127636537411908929
   PubMed Web of Science ®Google Scholar
• YanTDBlackDSavadyRSugarbakerPHSystematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinomaJ Clin Oncol200624244011401916921055
   PubMed Web of Science ®Google Scholar
• YanTDBlackDSavadyRSugarbakerPHA systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritoneiAnn Surg Oncol200714248449217054002
   PubMed Web of Science ®Google Scholar
• YanTDWelchLBlackDSugarbakerPHA systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesotheliomaAnn Oncol200718582783417130182
   PubMed Web of Science ®Google Scholar
• ChuaTCRobertsonGLiauwWFarrellRYanTDMorrisDLIntraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current resultsJ Cancer Res Clin Oncol2009135121637164519701772
   PubMed Web of Science ®Google Scholar
• DedrickRLMyersCEBungayPMDeVitaVTJrPharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancerCancer Treat Rep1978621111626987
   PubMedGoogle Scholar
• FrancisPRowinskyESchneiderJHakesTHoskinsWMarkmanMPhase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot studyJ Clin Oncol19951312296129678523061
   PubMed Web of Science ®Google Scholar
• MarkmanMBBundyBNAlbertsDSPhase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology GroupJ Clin Oncol20011941001100711181662
   PubMed Web of Science ®Google Scholar
• AlbertsDSLiuPYHanniganEVIntraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancerN Engl J Med199633526195019558960474
   PubMed Web of Science ®Google Scholar
• WalkerJLArmstrongDKHuangHQIntraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group studyGynecol Oncol20061001273216368440
   PubMed Web of Science ®Google Scholar
• SprattJSAdcockRAMuskovinMSherrillWMcKeownJClinical delivery system for intraperitoneal hyperthermic chemotherapyCancer Res19804022562606766084
   PubMed Web of Science ®Google Scholar
• KusumotoTHoldenSAAraGTeicherBAHyperthermia and platinum complexes: time between treatments and synergy in vitro and in vivoInt J Hyperthermia19951145755867594810
   PubMed Web of Science ®Google Scholar
• SugarbakerPHLaboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapyInt J Hyperthermia200723543144217701534
   PubMed Web of Science ®Google Scholar
• TentesAAKakolyrisSKyziridisDKaramveriCCytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy in the treatment of advanced epithelial ovarian cancerJ Oncol20122012358341
   Google Scholar
• KonigsrainerIBeckertSBeckerSCytoreductive surgery and HIPEC in peritoneal recurrent ovarian cancer: experience and lessons learnedLangenbecks Arch Surg201139671077108121842290
   PubMed Web of Science ®Google Scholar
• FagottiACostantiniBVizzielliGHIPEC in recurrent ovarian cancer patients: morbidity-related treatment and long-term analysis of clinical outcomeGynecol Oncol2011122222122521543112
   PubMed Web of Science ®Google Scholar
• Cascales CamposPAGil MartinezJGalindo FernandezPJPerioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancerEur J Surg Oncol6201137654354821489742
   PubMed Web of Science ®Google Scholar
• ParsonENLentzSRussellGShenPLevineEAStewartJHOutcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface dissemination from ovarian neoplasmsAm J Surg2011202448148621474115
   PubMed Web of Science ®Google Scholar
• SpiliotisJVaxevanidouASergouniotisFLambropoulouEDatsisAChristopoulouAThe role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of recurrent advanced ovarian cancer: a prospective study [abstract]J BUON2011161747921674853
   PubMed Web of Science ®Google Scholar
• DeracoMKusamuraSVirziSCytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trialGynecol Oncol2011122221522021665254
   PubMed Web of Science ®Google Scholar
• RovielloFPintoECorsoGSafety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancerJ Surg Oncol2010102666367020721959
   PubMed Web of Science ®Google Scholar
• PomelCFerronGLorimierGHyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC studyEur J Surg Oncol201036658959320466507
   PubMed Web of Science ®Google Scholar
• CeelenWPVan NieuwenhoveYVan BelleSDenysHPattynPCytoreduction and hyperthermic intraperitoneal chemoperfusion in women with heavily pretreated recurrent ovarian cancerAnn Surg Oncol20091972352235920039210
   PubMed Web of Science ®Google Scholar
• LimMCKangSChoiJHyperthermic intraperitoneal chemotherapy after extensive cytoreductive surgery in patients with primary advanced epithelial ovarian cancer: interim analysis of a phase II studyAnn Surg Oncol2009164993100019169758
   PubMed Web of Science ®Google Scholar
• BerederJGlehenOHabreJCytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from ovarian cancer: a multiinstitutional study of 246 patientsJ Clin Oncol200927Suppl 15 Abstract 5542
   Web of Science ®Google Scholar
• PavlovMJKovacevicPACeranicMSStamenkovicABIvanovicAMKecmanovicDMCytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer – 12-year single center experienceEur J Surg Oncol200935111186119119356887
   PubMed Web of Science ®Google Scholar
• GuardiolaEDelroeuxDHeydBIntra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancerWorld J Surg Oncol200971419203351
   PubMed Web of Science ®Google Scholar
• Di GiorgioANaticchioniEBiacchiDCytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancerCancer2008113231532518473354
   PubMed Web of Science ®Google Scholar
• BaeJHLeeJMRyuKSTreatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgeryGynecol Oncol2007106119320017466362
   PubMed Web of Science ®Google Scholar
• CotteEGlehenOMohamedFCytoreductive surgery and intraperitoneal chemo-hyperthermia for chemo-resistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patientsWorld J Surg20073191813182017629740
   PubMed Web of Science ®Google Scholar
• RaspagliesiFKusamuraSCampos TorresJCCytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of MilanEur J Surg Oncol200632667167516621425
   PubMed Web of Science ®Google Scholar
• GoriJCanstañoRTozianoMIntraperitoneal hyperthermic chemotherapy in ovarian cancerInt J Gynecol Cancer200515223323915823105
   PubMed Web of Science ®Google Scholar
• LookMChangDSugarbakerPHLong-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneumInt J Gynecol Cancer2004141354114764027
   PubMed Web of Science ®Google Scholar
• RyuKSKimJHKoHSEffects of intraperitoneal hyperthermic chemotherapy in ovarian cancerGynecol Oncol200494232533215297169
   PubMed Web of Science ®Google Scholar
• ZanonCClaraRChiappinoICytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancerWorld J Surg200428101040104515573262
   PubMed Web of Science ®Google Scholar
• ChatzigeorgiouKEconomouSChrysafisGTreatment of recurrent epithelial ovarian cancer with secondary cytoreduction and continuous intraoperative intraperitoneal hyperthermic chemoperfusion (CIIPHCP)Zentralbl Gynakol20031251042442914628225
   PubMedGoogle Scholar
• CavaliereFPerriPDi FilippoFTreatment of peritoneal carcinomatosis with intent to cureJ Surg Oncol2000741414410861608
   PubMed Web of Science ®Google Scholar
• du BoisAQuinnMThigpenT2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)Ann Oncol200516Suppl 8S7S12
   Web of Science ®Google Scholar
• du BoisALückHJMeierWfor Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study GroupA randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancerJ Natl Cancer Inst200395171320132912953086
   PubMed Web of Science ®Google Scholar
• OzolsRFBundyBNGreerBEfor Gynecologic Oncology GroupPhase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group studyJ Clin Oncol200321173194320012860964
   PubMed Web of Science ®Google Scholar
• McGuireWPHoskinsWJBradyMFCyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancerN Engl J Med19963341167494563
   PubMed Web of Science ®Google Scholar
• AlettiGDNordquistDHarmannLGallenbergMLongHJClibyWAFrom randomized trial to practice: single institution experience using the GOG 172 i.p. chemotherapy regimen for ovarian cancerAnn Oncol20102191772177820139154
   PubMed Web of Science ®Google Scholar
• ChuaTCHelmCWRobertsonGMorrisDLEstablishing evidence for change in ovarian cancer surgery – proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosisGynecol Oncol2009115116616819604568
   PubMed Web of Science ®Google Scholar
• de BreeEHelmCWHyperthermic intraperitoneal chemotherapy in ovarian cancer: rationale and clinical dataExpert Rev Anticancer Ther201212789591122845405
   PubMed Web of Science ®Google Scholar
• PfistererJPlanteMVergoteIGemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCGJ Clin Oncol200624294699470716966687
   PubMed Web of Science ®Google Scholar
• FerrandinaGLudovisiMDe VincenzoRDocetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II studyAnn Oncol20071881348135317470449
   PubMed Web of Science ®Google Scholar
• AravantinosGBafaloukosDFountzilasGPhase II study of docetaxel – vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancerAnn Oncol20031471094109912853352
   PubMed Web of Science ®Google Scholar
• ChuaTCYanTDSaxenaAMorrisDLShould the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortalityAnn Surg2009249690090719474692
   PubMed Web of Science ®Google Scholar
• ElattarABafaloukosDWinter-RoachBAHatemMNaikROptimal primary surgical treatment for advanced epithelial ovarian cancerCochrane Database Syst Rev2011108CD00756521833960
   PubMed Web of Science ®Google Scholar
• FujiwaraKAotaniEHamanoTA randomized Phase II/III trial of 3 weekly intraperitoneal versus intravenous carboplatin in combination with intravenous weekly dose-dense paclitaxel for newly diagnosed ovarian, fallopian tube and primary peritoneal cancerJpn J Clin Oncol20114127828220937602
   PubMed Web of Science ®Google Scholar
• FujiwaraKThree ongoing intraperitoneal chemotherapy trials in ovarian cancerJ Gynecol Oncol2012232757722523620
   PubMed Web of Science ®Google Scholar
• VotanopoulousKIhemelanduCShenPStewartJRussellGLevineEAA comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin CJ Surg Res Epub March 10, 2012 [ahead of print]
   Web of Science ®Google Scholar